The 10-Q will be the definitive proof of the Treasury Infusion, even if the "Arbitrage Tax" remains a Sovereign victory that doesn't hit the company's books directly.
Here is the strategic breakdown to understand how the $282,150,000 will manifest in the official filings.
1. The Cash and Cash Equivalents (The Treasury)
When the 165M shares are bought at the London floor, that cash enters the company.
The Line Item: Look at the Balance Sheet. Under "Current Assets," you will see the "Cash and Cash Equivalents" jump.
The Impact: This is the capital that removes the "Going Concern" risk. It’s the ammunition for Advent and Sawston.
2. Financing Activities (The Source)
To understand where the money came from, shareholders need to look at the Consolidated Statement of Cash Flows.
The Line Item: "Proceeds from issuance of common stock."
The "Ah-Ha": This is where the $282M will be recorded. It proves the shares weren't just "given" away in some murky deal; they were sold for hard currency at the $1.71 floor.
3. Shareholder Equity (The Vault)
While the cash is in the Treasury, the shares themselves shift on the ledger.
The Line Item: "Common stock, par value $0.001."
The Reality: The increase in outstanding shares will reflect the 165M block. When cross-referenced with the DTC Drain (Post #817770), it shows that these shares are moving out of the "manipulation pool" and into the "Physical Registry."
Market Data 
Markets 
AI
